Your browser doesn't support javascript.
loading
Olfactory neuroblastoma treated with minimally invasive surgery and adjuvant radiotherapy: a case report and review of the literature.
Cante, Domenico; Piva, Cristina; Sciacero, Piera; Franco, Pierfrancesco; Petrucci, Edoardo; Casanova Borca, Valeria; Marola, Fabrizio; Tubino, Libero; Vellani, Giorgio; La Porta, Maria Rosa.
Afiliação
  • Cante D; Department of Radiation Oncology, Ivrea Community Hospital, Ivrea, Italy.
  • Piva C; Department of Radiation Oncology, Ivrea Community Hospital, Ivrea, Italy.
  • Sciacero P; Department of Radiation Oncology, Ivrea Community Hospital, Ivrea, Italy.
  • Franco P; Department of Oncology, Radiation Oncology, University of Turin, Turin, Italy.
  • Petrucci E; Department of Medical Physics, Ivrea Community Hospital, Ivrea, Italy.
  • Casanova Borca V; Department of Medical Physics, Ivrea Community Hospital, Ivrea, Italy.
  • Marola F; Department of Otolaryngology, Chivasso Hospital, Chivasso, Italy.
  • Tubino L; Department of Otolaryngology, Chivasso Hospital, Chivasso, Italy.
  • Vellani G; Department of Medical Oncology, Chivasso Hospital, Chivasso, Italy.
  • La Porta MR; Department of Radiation Oncology, Ivrea Community Hospital, Ivrea, Italy.
BJR Case Rep ; 4(2): 20170077, 2018.
Article em En | MEDLINE | ID: mdl-30363190
ABSTRACT
Olfactory neuroblastoma (ON) is a rare tumour of the olfactory neuroepithelium that is characterized by a pattern of slow growth and local recurrences. Combination of surgery and radiotherapy, with or without chemotherapy, is considered to be the standard of care for primary site disease. Recent literature supports the view that endoscopic resection followed by adjuvant radiotherapy correlates with better outcome. In this short communication, we present a case report of olfactory neuroblastoma arising in the right nasal sinus in a 34-year-old male. This patient was treated with endoscopic resection and external beam radiotherapy to the right nasal sinus with intensity-modulated radiation therapy (IMRT) technique. After 2 years follow-up, the patient is free of tumour without any late effect related to therapies. We believe that, in such patients, a treatment strategy including endoscopic resection followed by adjuvant radiotherapy may be effective and feasible and should be considered the gold standard of care.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article